Seeing Is Believing
Currently out of the existing stock ratings of Jason Mills, 22 are a HOLD (10.48%), 186 are a BUY (88.57%), 2 are a SELL (0.95%).
Analyst Jason Mills, carries an average stock price target met ratio of 83.25% that have a potential upside of 23.15% achieved within 321 days. Previously, Jason Mills worked at CANACCORD, TD COWEN.
Jason Mills’s has documented 427 price targets and ratings displayed on 25 stocks. The coverage was on Healthcare, Industrials sectors.
Most recent stock forecast was given on TMDX, TransMedics Group at 06-May-2026.
Analyst best performing recommendations are on ELGX (ENDOLOGIX).
The best stock recommendation documented was for VAPO (VAPOTHERM) at 6/5/2020. The price target of $272 was fulfilled within 5 days with a profit of $30.16 (12.47%) receiving and performance score of 24.94.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 12-Apr-2022
$51
$5.31 (11.62%)
$57
11 days ago
(14-Oct-2026)
13/33 (39.39%)
$8 (18.60%)
151
Hold Since 07-Oct-2026
$48
$2.31 (5.06%)
$89
18 days ago
(07-Oct-2026)
20/29 (68.97%)
$6.42 (15.44%)
361
Hold Since 05-Oct-2026
$48
$2.31 (5.06%)
$50
20 days ago
(05-Oct-2026)
24/34 (70.59%)
$5.6 (13.21%)
249
Hold Since 30-Jul-2026
$48
$2.31 (5.06%)
$50
1 months 1 days ago
(24-Sep-2026)
18/25 (72%)
$3.32 (7.43%)
197
Buy Since 16-Jan-2026
$65
$19.31 (42.26%)
$85
1 months 4 days ago
(21-Sep-2026)
0/4 (0%)
$21.28 (48.67%)
Which stock is Jason Mills most bullish on?